These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 25714793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Albumin-bound paclitaxel: a next-generation taxane.
    Gradishar WJ.
    Expert Opin Pharmacother; 2006 Jun; 7(8):1041-53. PubMed ID: 16722814
    [Abstract] [Full Text] [Related]

  • 3. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel.
    Stinchcombe TE.
    Nanomedicine (Lond); 2007 Aug; 2(4):415-23. PubMed ID: 17716129
    [Abstract] [Full Text] [Related]

  • 4. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
    Sparreboom A, van Tellingen O, Nooijen WJ, Beijnen JH.
    Cancer Res; 1996 May 01; 56(9):2112-5. PubMed ID: 8616858
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.
    Petrelli F, Borgonovo K, Barni S.
    Expert Opin Pharmacother; 2010 Jun 01; 11(8):1413-32. PubMed ID: 20446855
    [Abstract] [Full Text] [Related]

  • 7. A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy.
    Yin T, Dong L, Cui B, Wang L, Yin L, Zhou J, Huo M.
    Int J Nanomedicine; 2015 Jun 01; 10():7397-412. PubMed ID: 26715846
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
    Malingré MM, Schellens JH, Van Tellingen O, Ouwehand M, Bardelmeijer HA, Rosing H, Koopman FJ, Schot ME, Ten Bokkel Huinink WW, Beijnen JH.
    Br J Cancer; 2001 Nov 16; 85(10):1472-7. PubMed ID: 11720431
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Albumin-bound Paclitaxel: in metastatic breast cancer.
    Robinson DM, Keating GM.
    Drugs; 2006 Nov 16; 66(7):941-8. PubMed ID: 16740010
    [Abstract] [Full Text] [Related]

  • 14. Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.
    Guarneri V, Dieci MV, Conte P.
    Expert Opin Pharmacother; 2012 Feb 16; 13(3):395-406. PubMed ID: 22263900
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Advances of paclitaxel formulations based on nanosystem delivery technology.
    Luo C, Wang Y, Chen Q, Han X, Liu X, Sun J, He Z.
    Mini Rev Med Chem; 2012 May 16; 12(5):434-44. PubMed ID: 22303950
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of paclitaxel-containing liposomes in rats.
    Fetterly GJ, Straubinger RM.
    AAPS PharmSci; 2003 Nov 21; 5(4):E32. PubMed ID: 15198520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.